Xu, Kefu et al. published their patent in 2012 |CAS: 23256-42-0

The Article related to poultry enterovirus syndrome veterinary drug preparation, Pharmacology: Effects Of Antimicrobials and Parasiticides and other aspects.HPLC of Formula: 23256-42-0

On April 11, 2012, Xu, Kefu published a patent.HPLC of Formula: 23256-42-0 The title of the patent was Veterinary drug composition for treating enterovirus syndrome of poultry and preparation method thereof. And the patent contained the following:

Veterinary drug composition for treating enterovirus syndrome of poultry and preparation method thereof are provided. The composition is composed of sulfaquinoxaline sodium 5-20, ciprofloxacin hydrochloride 5-15, trimethoprim lactate 1-4, vitamin K3 1-5, NaHCO3 5-20% and addnl. anhydrous glucose. The composition is prepared by pulverizing and sieving the materials resp., mixing according to proportion, then stirring uniformly. Sulfaquinoxaline sodium has strong therapic effect for Eimeria tenella combined with trimethoprim lactate to realize synergism to enhance greatly anti-coccidia ability, ciprofloxacin hydrochloride has strong effect of treating bacterial infection in enterovirus syndrome, so that cause of enterovirus syndrome can be aimingly treated. Vitamin K3 can control the adverse side effect of intestinal tract bleeding caused by enterovirus syndrome, and sodium hydrogen carbonate can reduce the kidney injury to poultry caused by sulfaquinoxaline sodium. The experimental process involved the reaction of 5-(3,4,5-Trimethoxybenzyl)pyrimidine-2,4-diamine 2-hydroxypropanoate(cas: 23256-42-0).HPLC of Formula: 23256-42-0

The Article related to poultry enterovirus syndrome veterinary drug preparation, Pharmacology: Effects Of Antimicrobials and Parasiticides and other aspects.HPLC of Formula: 23256-42-0

Referemce:
Pyrimidine | C4H4N2 – PubChem,
Pyrimidine – Wikipedia